Monarch Partners Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Monarch Partners Asset Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-163,755	Closed	-$3.88M	–	214
2017 Q4	$3.88M	Sell	163,755 -29,960	-15%	-$755K	0.36%	97
2017 Q3	$5.45M	Sell	193,715 -9,120	-4%	-$277K	0.53%	82
2017 Q2	$6.54M	Buy	202,835 +48,695	+32%	+$1.48M	0.65%	68
2017 Q1	$4.36M	Buy	+154,140	New	+$4.09M	0.44%	86

Other funds holding CSII

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Monarch Partners Asset Management's CSII Position: Q1 2018 in Review

Monarch Partners Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2018, closing a stake of 163,755 shares — an estimated $3.88M sold.

Monarch Partners Asset Management first reported a position in CSII in Q1 2017 and held it in 4 quarters. The position peaked at $6.54M in Q2 2017. 128 funds tracked by Wall St. Rank hold CSII as of Q1 2018.

Monarch Partners Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2018 after selling out during the quarter.
Monarch Partners Asset Management sold 163,755 Cardiovascular Systems, Inc. shares in Q1 2018, an estimated $3.88M.
Monarch Partners Asset Management first reported a position in Cardiovascular Systems, Inc. in Q1 2017 and held it in 4 quarters.
Monarch Partners Asset Management's Cardiovascular Systems, Inc. position peaked at $6.54M in Q2 2017.
128 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2018.

Based on Monarch Partners Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.